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Background: Work disability—a common outcome of rheumatoid arthritis (RA)—is a societal (for
example, financial costs) and individual problem (for example, loss of status, income, social support, and
distraction from pain and distress). Until now, factors that predict work disability in RA have not been
systematically reviewed.
Objective: To determine predictive factors of work disability in RA as reported in the literature.
Methods: A systematic literature search in Cinahl (1988–2004), Embase (1988–2004), and Medline
(1989–2004) was followed by the application of two sets of criteria related to: (a) methodological quality,
and (b) measurement of the predictive factor. Based on the quality and the consistency of the findings, a
rating system was used to assess the level of evidence for each predictive factor.
Results: Nineteen publications (17 cohorts) were identified, of which 13 met the general methodological
quality criteria. Results provided strong evidence that physical job demands, low functional capacity, old
age, and low education predict work disability in RA. Remarkably, biomedical variables did not
consistently predict work disability. Moreover, owing to the lack of high quality studies no evidence was
found for personal factors such as coping style, and work environmental factors such as work autonomy,
support, work adjustments that are presumed crucial in the work disablement process.
Conclusions: The results indicate that work disability in RA is a biopsychosocially determined misfit
between individual capability and work demands.
A
large number of patients with rheumatoid arthritis
(RA) are work disabled.1–4 The lowered RA-induced
work ability is a societal5 (for example, financial costs)
and individual problem6–10 (for example, loss of status,
income, social support, and distraction from pain and
distress).
Initially, the relation between RA and work disability was
examined from a biomedical perspective. From this perspec-
tive, disease activity (that is, inflammation) quantified as
erythrocyte sedimentation rate and number of tender or
swollen joints results in structural damage (that is, joint
damage and deformity). Structural damage, in turn, results
in limitations of physical functions, expressed as limited
mobility, strength, and manual dexterity. Work disability
may occur early owing to inflammatory processes or later in
this process owing to joint destruction.
The awareness that work disability is a misfit between
functional capability and work environmental demands11 has
instigated researchers to use models that explain work
disability from a biopsychosocial perspective.12–15 Promising
in this respect,16 is the International Classification of
Functioning, Disability and Health (ICF).17 The ICF organises
information into (a) (impaired) body functions or struc-
tures—disease activity and structural damage; (b) activity
(limitations); and (c) participation (restrictions) such as
work disability. In addition, contextual variables—namely,
(d) environmental and (e) personal variables are included
(fig 1).
With the recognition of work disability as a biopsychosocial
phenomenon, multidisciplinary programmes aimed at the
vocational rehabilitation of subjects with RA have been
introduced. De Buck et al showed that evidence of the
effectiveness of these programmes is limited.18 Owing to
methodological flaws, inadequate descriptions, and late
initiation, it remains uncertain at which factors these
programmes should be directed to promote work ability of
subjects with RA.
The lack of research which evaluates treatment early in the
RA work disablement process is reflected in a review by
Steultjens et al.19 This review showed that of the 37 studies
that evaluated occupational treatment in RA—facilitation of
performance of daily living activities—none had included
work disability as an outcome. Hence, the recognition that
prevention of work disability is preferable to rehabilitation is
not mirrored in an equal amount of research attention.
The scarcity of work disability prevention research is in
contrast with the many studies on predictive factors of work
disability.3 20–24 This article describes a systematic and critical
evidence synthesis of these studies.
METHODS
Search strategy
A search in March 2004 in (a) Cinahl (1988–2004), (b)
Embase (1988–2004), and (c) Medline (1988–2004) with the
following free text words in the title and abstract was
performed:
(1) rheumatoid arthritis
(2) work < working < worker < workers < occupation <
occupations < occupational < vocation < vocational <
labor < labour < job < jobs < employ < employment
(3) ability < abilities < able < disablement < disabled <
unable < disability < disabilities < capability <
capabilities < capable < incapable < functioning <
performance < dysfunction < capacity < participation
Abbreviations: DMARD, disease modifying antirheumatic drug; ICF,
International Classification of Functioning, Disability and Health; RA,
rheumatoid arthritis; RF+, rheumatoid factor positivity
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Combination of these words (1 > 2 > 3) resulted in 765
hits of which only English publications that described
empirical research or reviews were retained. This resulted
in 391 publications to be included in subsequent selection
steps.
Selection
The first reviewer (EdC) made a selection of the identified
papers. To check the reproducibility, the second reviewer
(JKS) repeated the selection in a random sample (n=50)
from the papers identified initially. In cases of doubt (,4%),
consensus was reached. Firstly, studies were included on the
basis of title and abstract. For this purpose two inclusion
criteria were formulated: (a) the study population consists of
subjects with RA, and (b) the study examines work
(dis)ability or equivalent concepts as the outcome.
Thereafter, studies with a prospective, retrospective cohort,
or case-control design were included on the basis of the
abstract or full report.
Methodological quality assessment
Firstly, based on eight criteria25 (table 1) studies were
classified as high (.6 criteria), medium (4–5 criteria), or
low quality (,4 criteria). Low quality studies were excluded
from the review. Thereafter, the studies remaining had to
ascertain that (a) the instruments that were used were
(psycho)metrically sound and (b) the predictive factor
chronologically preceded work disability.
Best evidence synthesis
The information was synthesised into four evidence levels:
(a) no evidence:(1 study available; (b) weak evidence: 2 studies
available that find a significant association in the same
direction or 3 studies available, of which 2 find a significant
association in the same direction and the third study finds no
significant association; (c) strong evidence: 3 studies available
that find an association in the same direction or .4 studies
available, of which .66% find a significant association in the
same direction and no more than 25% find an opposite
association; and (d) inconsistent evidence: remaining cases.
Finally, weak or strong evidence for ‘‘no association’’ is
provided when .4 studies are available, of which .75% and
.85%, respectively, find no association.
RESULTS
Selection and methodological quality assessment
The search resulted in 391 citations. Application of the
inclusion criteria resulted in 19 papers that presented 17
studies. Three papers described baseline,7 5 year,26 and
10 year27 follow up results of the same sample. Only the
10 year follow up article27 was included. All papers provided
valuable information on work disability in RA, but varied in
the scores on the quality criteria formulated for the purpose
of this study. In particular, six, seven, and four studies were
Figure 1 ICF model applied to work disability in RA.
Table 1 Information on design, sample size, duration of follow up, disease duration, and quality criteria of the 17 studies
Information
Reference number
3 28 29 30 2 31 13 32 33 4 34 27 1 35 36 37 38
Design P P P P P P R R R R P P P R R R R
Sample size (n) 149 83 –` 73 82 732 175 720 659 119 86 497 436 469 162 122 69
Duration of follow up (years) 9 2 10 6 10 5 – – – – 8 9 18 – – – –
Disease duration (years)
Mean (SD) 4 (1) – – – 0.5 (–) – 11 – – 2 (1) – – 5 (7) 7 (–) – – 13 (10)
Median – – – – – – 8 – – – – – – – – – –
Range – 0–2 – 0–1 0–2 0.5–1 – – – – 0–2 – – 1–42 – – –
Early RA (,5 years, %) 100 100 – 100 100 100 – 19 25 100 100 39 – – – 34 –
Late RA (.5 years, %) 0 0 – 0 0 0 – 81 75 0 0 61 – – – 66 –
Quality criteria
1. Were patients diagnosed in line with (revised)
ACR criteria?
+ + – + + + + – – + + + + – + + +
2. Was the sample representative? + + + + + + + + + + + + – + + + –
3. Were the patients able to work at baseline?* + + + + + + + + – + + + + + + + +
4. Was baseline response .80% and loss to
follow up ,30%?
+ + + + + + + – + + + – – – – – +
5. Was the follow up .1 year? + + + + + + – – – – + + + – – – –
6. Was work disability defined as stopping work
owing to ill health/RA?
+ + + + + + + + + + – – + + – – –
7. Was an external criterion used to assess work
disability?
– + + + + – + + + – – – – – – – –
8. Was recall bias in the work disability assessment
avoided?
+ + + + + + – – – – + + – – – – –
Total quality score (0–8) 7 8 7 8 8 7 6 4 4 5 6 5 5 3 3 3 3
Quality label HQ HQ HQ HQ HQ HQ MQ MQ MQ MQ MQ MQ MQ LQ LQ LQ LQ
+, yes; –, no; P, prospective study; R, retrospective study; HQ, study of high quality; MQ, study of medium quality; LQ, study of low quality.
*Participants in the prospective studies must work at the start of the study, onset of RA must occur before work disability for the participants in the retrospective studies; retrospective studies
could not fulfil these criteria; `this research involved a population based study.
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Table 2 Results of the best evidence synthesis
Factor Studies Association Evidence (direction)
1. Factors that mirror RA directly
RF+ Sokka,2 Barrett,3 Wolfe,1 Mau30 No,2 3 positive1 30 Inconsistent
[Callahan,13 Young31 No13 31]
Disease duration Wolfe,1 Reisine,27 Callahan,13 De Roos,33 Chorus32 No,1 27 positive13 32 33 Inconsistent
2.Impaired body function or body structure
Variables of disease activity Inconsistent
ESR Sokka,2 Borg,28 Wolfe,1 Young31 No,2 28 positive1 31
[Callahan,13 Doeglas4 No,13 positive4]
Tender joints Wolfe1 Positive1
[Callahan,13 Young31 Positive13 31]
Inflamed, swollen or flared joints Sokka,2 Reisine,27 Borg,28 Mau30 No,2 27 28 positive30
[Callahan,13 Fex,34 Young31 No,13 positive31 34]
Patient’s or physician’s global
assessment
Borg,28 Wolfe1
[Sokka,2 Callahan13
No,28 positive1
Positive2 13]
Pain and emotional functions
Pain Reisine,27 Borg,28 Wolfe1 No,27 28 positive1 Inconsistent
[Fex,34 Sokka,2 Callahan,13 Young,31 De Roos33 No,34 positive2 13 31 33]
Emotional functions Fex,34 Borg,28 Wolfe1 No,34 positive1 28 Weak (positive)
[De Roos33 Positive33]
Structural damage Sokka,2 Reisine,27 Young,31 Mau30 No,2 27 positive30 31 Inconsistent
[Fex,34 Callahan13 No,34 positive13]
3. Activity limitations
(Modified) HAQ-disability Wolfe,1 Sokka,2 Barrett,3 Fex,34 Young,31 Borg28 Positive1–3 28 31 34 Strong (positive)
[Callahan,13 Doeglas,4 De Roos,33 Chorus32 Positive4 13 32 33]
Grip strength Wolfe1 Negative1 No
[Callahan13 Negative13]
Morning stiffness (min) [Callahan13 No13]
Absenteeism [Reisine27 Positive27] No
4. (Work) environment
Work autonomy Reisine27 No27 No
[Fex34 No34]
Job transition Sokka2 Negative2 No
[Chorus32 Negative32]
Job training after diagnosis [Chorus32 Negative32] No
Workplace accessibility/mobility [Chorus32 Negative32] No
Work adjustments [Chorus32 Negative32] No
Support at work [Chorus32 Negative32] No
Complexity of working with things [Wolfe1 No1] No
Complexity of working with data [Wolfe1 Negative1] No
Supervising others Reisine,27 Chorus,32 Wolfe1 No,27 32 negative1 Inconsistent
Physical job demands
Self reported [Reisine,27 Fex,34 Mau30 Positive27 30 34] Strong (positive)
Occupation Barrett,3 Wolfe,1 Sokka,2 Callahan,13 Reisine27 Holte,29
Young,31 De Roos,33 Chorus,32 Borg28
No,3 positive1 2 13 27–29 31–33
Self employment Reisine27 Negative27 No
Working hours Reisine,27 Holte29 Negative27 29 Weak (negative)
[Chorus32 Negative32] No
Company size Chorus32 No32 No
Temporary job position Chorus32 No32 No
Career opportunities [Chorus32 Negative32] No
Job satisfaction [Fex,34 Reisine27 No27 34] No
Financial situation Reisine,27 Borg,28 Holte29 No,27 28 negative29 Inconsistent
Impact of RA on family role Reisine27 No27 No
Social support Reisine27 No27 No
Car/stair deprivation [Young31 Positive31] No
5. Person
Age Barrett,3 Sokka,2 Callahan,13 Reisine,27 Doeglas4 Fex,34
Young,31 Mau,30 De Roos,33 Chorus,32 Borg28
No,3 positive2 4 13 27 28 30–34 Strong (positive)
Sex Sokka,2 Barrett,3 Callahan,13 Reisine,27 Fex,34 Borg,28
Wolfe,1 Young,31 De Roos,33 Chorus32
No,2 3 13 27 28 34 yes1 31–33 Inconsistent
Marital status Callahan,13 Reisine,27 Holte,29 Fex,34 De Roos,33
Borg,28 Sokka2
No,13 27–29 33 34 yes2 Strong (no)
Education Barrett,3 Holte,29 Borg,28 Reisine,27 Wolfe,1 Sokka2
Callahan,13 Doeglas,4 Fex,34 De Roos33 Chorus32
No,3 28 29 negative1 2 4 13 27 32–34 Strong (negative)
Race Callahan,13 Wolfe,1 De Roos33 No,13 yes1 33 Weak (non-white R
work disability)
BMI Wolfe1 Positive1 No
Desire for paid work [Reisine27 No27 No]
Comorbid conditions [Callahan13 Positive13 No]
Coping [Callahan,13 Chorus32 Positive13 32 No]
Note. Studies between brackets were not taken into account in the evidence synthesis.
Positive association, the presence of the factor or a higher level of the factor increases the chance of future work disability; negative association, the presence of the
factor or a higher level of the factor decreases the chance of future work disability; RF+, rheumatoid factor positivity; ESR, erythrocyte sedimentation rate; BMI,
body mass index.
The evidence synthesis is based on the univariate associations when available or the multivariate associations when univariate associations are unavailable.
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rated as high, medium, and low quality, respectively (table 1).
This review is based on the 13 high or medium quality
studies.
Definition and measurement of work disability
Two studies did not embody RA or ill health as a reason for
work termination in the work disability definition (criterion
6).27 34 Six studies did not include an external criterion for the
work disability measurement (criterion 7).1 3 4 27 31 34 Five
studies1 4 13 32 33 asked work disabled subjects with RA to
recall whether work disability occurred before or after disease
onset (criterion 8).
Predictive factors of work disability
Factors that mirror RA directly
Rheumatoid factor positivi ty (RF+)
Two prospective studies1 30 found a positive and two
prospective studies2 3 found no association between RF+
and work disability. Two studies13 31 measured RF+ after work
disability, and, therefore, were not taken into account.
Therefore, the evidence that patients with RA with RF+ have
an increased chance of work disability is inconsistent.
Disease duration
Eight studies1 2 4 13 27 30 32 33 reported an association between
disease duration and work disability. Three studies were not
taken into account because they were conducted among
patients with early RA in the same stage of the disease.2 4 30
(see table 1 for information on disease duration for each
study). Of the five remaining studies, three13 32 33 found a
positive and two1 27 found no association. Thus the evidence
that employed patients with RA with long disease duration
have an increased chance of work disability is inconsistent.
Impaired body function or body structure
Variables of disease activity
Nine studies1 2 4 13 27 28 30 31 34 examined the association
between variables of disease activity and work disability.
Studies that quantified variables of disease activity averaged
over time or after work disability occurred were not taken into
account in the analyses (shown between brackets in table 2).
Synthesis of the remaining evidence discloses inconsistent
evidence that subjects with RA with high disease activity
have an increased chance of becoming work disabled.
Pain and emotional functions
Eight studies examined the association between pain and
work disability.1 2 13 27 28 31 33 34 Five studies were not taken
into account because they only reported on the cross sectional
association or on the association between joint pain over time
and work disability (shown between brackets in table 2).
Synthesis of the three remaining studies demonstrates
inconsistent evidence that subjects who experience high pain
are more likely to become work disabled. Four studies1 28 33 34
investigated the role of emotional functions (that is,
psychological distress, helplessness, depression, and anxiety)
in the work disablement process. One retrospective study33
assessed emotional functions—namely, helplessness, after
work disability, and, therefore, was not included in the
evidence synthesis. Combination of the three remaining
prospective studies resulted in weak evidence that patients
with RA with emotional problems run an increased work
disability risk.
Structural damage
Six studies2 13 27 30 31 34 inspected the relationship between
structural damage and work disability. Two studies13 34
reported on the cross sectional association between the two
variables and, therefore, were not taken into account.
Analyses of the four other studies provided inconsistent
evidence that structural damage predicts work disability.
Activity limitations
Six prospective1–3 28 31 34 and four retrospective studies4 13 32 33
demonstrated a positive association between low functional
capacity, assessed by the (modified) Health Assessment
Questionnaire (HAQ-disability)39 and work disability.
Because the retrospective studies measured HAQ-disability
in subjects with RA who were already work disabled, they
were not taken into account in the evidence synthesis. In
conclusion, there is strong evidence that patients with RA
with many activity limitations, expressed as high HAQ-
disability, have an increased chance of becoming work
disabled.
(Work) environmental factors
All studies except that of Doeglas et al4 investigated at least
one environmental work disability predictor. Studies that (a)
reported cross sectional associations; (b) did not provide
psychometric information on the questionnaires; or (c) asked
patients with RA to recall subjective work related information
(for example, working hours before work disability occurred)
were not taken into account in the evidence synthesis
(displayed between brackets in table 2). Synthesis of the
remaining evidence shows (a) there is inconsistent evidence
that patients with RA who supervise others have a lowered
chance of work disability; (b) there is strong evidence that
patients with RA employed in physically demanding occupa-
tions have an increased chance of becoming work disabled;
(c) there is weak evidence that patients with RA with a part-
time job (that is, small number of working hours) have an
increased chance of work disability; and (d) there is
inconsistent evidence for an association between the finan-
cial situation of the patients with RA and the occurrence of
work disability.
Personal factors
Personal factors that are stable over time (that is, age, sex,
marital status, educational level, and race) were frequently
examined as predictive factors of work disability. Synthesis of
these studies shows that (a) there is strong evidence that
older patients with RA have an increased chance of becoming
work disabled; (b) there is inconsistent evidence that women
with RA have an increased chance of work disability; (c)
there is strong evidence for no association between marital
status and work disability; (d) there is strong evidence that
less educated patients with RA are more likely to become
work disabled; and (e) there is weak evidence that non-white
patients with RA have an increased risk of work disability.
Remaining variables
Owing to lack of information for several variables ‘‘no’’
evidence was found. Table 2 displays these variables, which
include, among others, morning stiffness, grip strength, and
absenteeism (indicators of activity limitations), work auton-
omy, job satisfaction, support at work, the impact of RA on
family roles, car/stair deprivation (environmental variables),
desire for paid work, the presence of comorbid conditions,
and behavioural coping styles (personal variables).
DISCUSSION
This review shows that physical job demands and HAQ-
disability—a correlate of structural damage, disease activity,
pain, and psychological factors40 41—predict work disability.
Contrarily, this review failed to supply consistent evidence for
the direct effect of (bio)medical variables on work disability.
This indicates that reliance on biomedical models is
insufficient to explain work disability.11–14 16 42 It confirms
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that work disability is a biopsychosocially determined misfit
between work environmental demands and individual
capability.
Other reviews3 20–24 have also concluded that physical job
demands, HAQ-disability, old age, and low education predict
work disability. Conversely, the lack of evidence for
biomedical variables as work disability predictors contradicts
one review.23 Our reliance on studies which ascertained that
the predictive factor under study preceded work disability
may explain this discrepancy. The studies that did not
ascertain this sequential association found a significant
positive association more frequently. Presumably, as noted
by Wolfe and Hawley,1 compared with subjects with RA who
remain employed, disease progression is less favourable
among subjects who become work disabled. Also, work
disability itself may stimulate disease progression7 8 43
because of the loss of psychosocial, financial, and medical
benefits (for example, esteem, social support, distraction,
income, insurance, and medical care).
Five other aspects of this review warrant comment. Firstly,
it should be noted that we used the term ‘‘predictive factor’’
to describe a statistical and not, necessarily, an aetiological
association between the predictive factor under study and
work disability.
Secondly, although work disability increases during the
course of the disease,1 6 34 44 we did not find consistent
evidence that disease duration predicts work disability. The
different effect of RA on work disability during the course of
the disease may explain this inconsistency. Disease activity
may affect work disability most dramatically in early
disease,45 whereas structural damage and illness factors
may become more important in late disease.27 45
Unfortunately, we could not gain a clear understanding of
work disability predictors in early, compared with late,
disease because only three studies28 30 46 examined predictors
in the first 5 years of the disease.
Thirdly, studies that examined drug treatment were not
included in the synthesis. Given the beneficial effects on
structural damage and functional capacity of treatment with
biological agents and combination of disease modifying
antirheumatic drugs (DMARDs),47 48 such treatment may
influence work disability substantially. Recent studies sup-
port this presumed beneficial effect.28 49–51 Borg et al, for
instance, found that early treatment with a DMARD (namely,
auranofin) delayed work disability.28 Bresnihan et al showed
that early treatment with a biological agent (that is,
anakinra) increased the number of productive days.51
Furthermore, Yelin and colleagues showed that early
DMARD treatment (with etanercept) was associated with
longer weekly working hours.49 Finally, Puolakka et al
demonstrated that early DMARD combination treatment
decreased sickness absence in comparison with single
DMARD treatment.50 Although more research is required,
the results, so far, indicate that in addition to non-medical
interventions,52 medical treatment in early RA may prevent
work disability.
Fourthly, because the synthesis took only statistically
significant associations into account, our conclusions are on
the safe side. Particularly, clinically significant, but statisti-
cally non-significant effects in studies with few patients with
RA might have reached statistical significance with larger
sample sizes. Consequently, it may be argued that in some
instances we have wrongly concluded that no clinically
relevant effect exists. However, considering the number of
patients in each study—which was at least 73—the statistical
power of each study seems sufficient to demonstrate
clinically relevant effects.
Fifthly, this review showed that old and less educated
subjects with RA are more likely to become work disabled.
Presumably, these subjects are comparatively unhealthy, are
more often employed in physically demanding occupations,
and are less likely to find alternative employment or to have
high socioeconomic status.1 These characteristics, in turn,
predict work disability.
The role of other personal factors was examined also.
Reisine et al disproved the suggestion that work disability
results from a low desire for paid work.27 Furthermore, work
disabled subjects with RA were found to more frequently
report emotional problems, adverse coping styles, a lack of
work adjustment, job training, and support at work28 32 33
than working subjects with RA. These studies are important
in highlighting work disability factors that are responsive to
intervention.
The studies about work environmental variables are
important for the same reason. However, these studies have
tended to use invalidated instruments or occupational title as
a proxy for the work characteristic under study. Studies that
used invalidated instruments were not taken into account in
the evidence synthesis. Studies that used the occupational
title53 were taken into account, but may not give a precise
representation of the work setting.54 Preferably, as noted by
Shanahan et al,55 studies on work demands estimate specific
tasks—for instance, repetitive movements of the hand, by the
use of validated self report scales and trained observers.
Following on from this, the challenge is to examine how
work disability predictors influence this phenomenon. For
this purpose, more research is needed that examines
variables such as employability, lifestyle, physical work tasks,
and coping styles that mediate or moderate the effect of
known work disability precursors such as age, education,
occupation, and HAQ-disability. This research may provide
more concrete cues for work disability prevention.
Based on the present results, interventions aimed at work
disability prevention should reduce physical job demands and
slow down functional disability. Reduction of physical job
demands may be brought about through job accommoda-
tion56 or by encouraging and assisting subjects with RA in
physically demanding jobs to move to physically less
demanding jobs. Obviously, the success of these interven-
tions depends on employability, alternative employment
availability, and re-education opportunities. Because low
functional disability (HAQ-disability) integrates structural
damage, disease activity, pain, and psychological factors,40
interventions that slow functional disability require treat-
ment of the disease,57 and related problems.
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